Anti-fibrotic effects of the IP receptor agonist
Not Applicable
Recruiting
- Conditions
- pulmonary arterial hypertension associated with systemic sclerosisD012595
- Registration Number
- JPRN-jRCT1011210052
- Lead Sponsor
- Atsumi Tatsuya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
1. Males and females aged 18 or more
2. Needs to be treated with selective pulmonary vasodilators
3. Capable of giving signed informed consent
Exclusion Criteria
1. Lactating or pregnant females
2. Strongly suspected of structural brain abnormality
3. Unable to undergo the proper procedure of chest CT
4. Needs to be treated with anti-fibrotic drugs
5. Prior or current receipt of anti-fibrotic drugs
6. Inappropriate in the option of the Investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method